Are you Dr. Poirier?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Childrens Ln
Norfolk, VA 23507Phone+1 757-668-9222Fax+1 757-668-7568
Summary
- Dr. Michael Poirier, MD is a pediatric emergency medicine physician in Norfolk, Virginia. He is currently licensed to practice medicine in Virginia, Ohio, and Georgia. He is affiliated with Children's Hospital of The King's Daughters and is an Associate Professor at Eastern Virginia Medical School.
Education & Training
- University of Alabama Medical CenterResidency, Pediatrics, 1990 - 1993
- University of Alabama School of MedicineClass of 1990
Certifications & Licensure
- VA State Medical License 1996 - 2026
- OH State Medical License 1994 - 1996
- GA State Medical License 1993 - 1995
- AL State Medical License 1991 - 1993
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Emergency Medicine
Awards, Honors, & Recognition
- Fellow (FACEP) American College of Emergency Physicians
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 9 citationsPropofol Versus Dexmedetomidine for Procedural Sedation in a Pediatric Population.Nicole M Schacherer, Tamara M. Armstrong, Amy M. Perkins, Michael P Poirier, James M Schmidt
Southern Medical Journal. 2019-05-01 - 2 citationsEmergency Department Diagnosis of Dietl Crisis in a 7-Year-Old Girl With Abdominal Pain.James Burhop, Joel Clingenpeel, Michael P. Poirier
Pediatric Emergency Care. 2016-06-01 - 4 citationsInternal Applicants to Pediatric Emergency Medicine Fellowships and Current Use of the National Resident Matching Program Match: A Survey of Fellowship Directors.Timothy Bradley, Joel Clingenpeel, Michael P. Poirier
Pediatric Emergency Care. 2015-07-01
Press Mentions
- Qualigen Calls It Quits on COVID Antiviral After Pouring Millions into R&DAugust 17th, 2021
- Qualigen Therapeutics, Inc. Provides Update on Product Development Priorities and Reports Second Quarter and Six Month 2021 Financial ResultsAugust 17th, 2021
- Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19July 14th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow